These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 37445809)
1. Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment. De Siervi S; Cannito S; Turato C Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445809 [TBL] [Abstract][Full Text] [Related]
2. [The clinical picture, diagnosis and treatment of chronic liver diseases (a lecture)]. Burchinskiĭ GI Lik Sprava; 1993 Jul; (7):14-23. PubMed ID: 8209525 [TBL] [Abstract][Full Text] [Related]
3. Zinc supplementation and its benefits in the management of chronic liver disease: An in-depth literature review. Bloom A; Bloom S; Silva H; Nicoll AJ; Sawhney R Ann Hepatol; 2021; 25():100549. PubMed ID: 34614431 [TBL] [Abstract][Full Text] [Related]
4. Treatment for restless legs syndrome secondary to chronic liver disease: a case report. Oguri T; Sugiyama H; Hamano T; Tachibana N Intern Med; 2012; 51(8):933-4. PubMed ID: 22504254 [TBL] [Abstract][Full Text] [Related]
5. Classification and treatment of chronic active liver disease. Geall MG; Schoenfield LJ; Summerskill WH Gastroenterology; 1968 Dec; 55(6):724-9. PubMed ID: 5727785 [No Abstract] [Full Text] [Related]
6. The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital. Yang Y; Zhang XZ; Ng HS; Fong JC; Lee LH Thromb Res; 2015 Sep; 136(3):548-51. PubMed ID: 26164397 [TBL] [Abstract][Full Text] [Related]
7. [Pathogenesis of chronic liver diseases. Thoughts on their treatment]. Brühl W Med Welt; 1970 Jun; 26():1181-6. PubMed ID: 5522885 [No Abstract] [Full Text] [Related]
8. Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review). Consolo M; Amoroso A; Spandidos DA; Mazzarino MC Int J Mol Med; 2009 Aug; 24(2):143-52. PubMed ID: 19578787 [TBL] [Abstract][Full Text] [Related]
9. Management of polycystic liver disease. Cheung J; Scudamore CH; Yoshida EM Can J Gastroenterol; 2004 Nov; 18(11):666-70. PubMed ID: 15565206 [TBL] [Abstract][Full Text] [Related]
10. Unexplained chronic liver disease in Ethiopia: a cross-sectional study. Orlien SMS; Ismael NY; Ahmed TA; Berhe N; Lauritzen T; Roald B; Goldin RD; Stene-Johansen K; Dyrhol-Riise AM; Gundersen SG; Morgan MY; Johannessen A BMC Gastroenterol; 2018 Feb; 18(1):27. PubMed ID: 29439653 [TBL] [Abstract][Full Text] [Related]
11. Medical management of chronic cholestatic liver diseases. Gossard AA; Lindor KD Can J Gastroenterol; 2000 Nov; 14 Suppl D():93D-98D. PubMed ID: 11110620 [TBL] [Abstract][Full Text] [Related]
12. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis. Frieden TR; Ozick L; McCord C; Nainan OV; Workman S; Comer G; Lee TP; Byun KS; Patel D; Henning KJ Hepatology; 1999 Mar; 29(3):883-8. PubMed ID: 10051493 [TBL] [Abstract][Full Text] [Related]
13. Managing diabetes and liver disease association. Hamed AE; Elsahar M; Elwan NM; El-Nakeep S; Naguib M; Soliman HH; Ahmed Aboubakr A; AbdelMaqsod A; Sedrak H; Assaad SN; Elwakil R; Esmat G; Salh S; Mostafa T; Mogawer S; Sadek SE; Saber MM; Ezelarab H; Mahmoud AA; Sultan S; El Kassas M; Kamal E; ElSayed NM; Moussa S Arab J Gastroenterol; 2018 Dec; 19(4):166-179. PubMed ID: 30420265 [TBL] [Abstract][Full Text] [Related]
14. The rheological profile of chronic liver disease patients in Nigeria. Omoti CE; Omuemu CE; Olu-Eddo AN Clin Hemorheol Microcirc; 2009; 42(4):279-84. PubMed ID: 19628893 [TBL] [Abstract][Full Text] [Related]
15. Calling a stage-based treatment model for chronic liver diseases in China mainland. Liu X; Xu J Ann Hepatol; 2020; 19(6):585-589. PubMed ID: 31711913 [TBL] [Abstract][Full Text] [Related]
16. Liver disease in pregnancy. Joshi D; James A; Quaglia A; Westbrook RH; Heneghan MA Lancet; 2010 Feb; 375(9714):594-605. PubMed ID: 20159293 [TBL] [Abstract][Full Text] [Related]
17. Liver injury in COVID-19: clinical features and treatment management. Yu D; Du Q; Yan S; Guo XG; He Y; Zhu G; Zhao K; Ouyang S Virol J; 2021 Jun; 18(1):121. PubMed ID: 34108015 [TBL] [Abstract][Full Text] [Related]
18. Chronic liver disease. The scope of causes and treatments. Babb RR Postgrad Med; 1992 May; 91(7):89-96. PubMed ID: 1589371 [TBL] [Abstract][Full Text] [Related]
20. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease]. Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]